Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease
Patients with Crohn’s disease (CD) are inclined to have platelet hyperactivity and an increased risk of intestinal micro-thrombosis. However, the mechanisms underlying platelet hyperactivity in CD are not well understood. We investigated the assembly of platelet NLRP3 inflammasome in patients with a...
Main Authors: | Ge Zhang, He Chen, Yifan Guo, Wei Zhang, Qiuyu Jiang, Si Zhang, Liping Han, She Chen, Ruyi Xue |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.705325/full |
Similar Items
-
NLRP3 Inflammasome and Inflammatory Bowel Disease
by: Yu Zhen, et al.
Published: (2019-02-01) -
The NLRP3 inflammasome: an emerging therapeutic target for chronic pain
by: Ruixiang Chen, et al.
Published: (2021-03-01) -
Role of the NLRP3 Inflammasome in Preeclampsia
by: Koumei Shirasuna, et al.
Published: (2020-02-01) -
Olive Leaf Extract (OleaVita) Suppresses Inflammatory Cytokine Production and NLRP3 Inflammasomes in Human Placenta
by: Yasuaki Kaneko, et al.
Published: (2019-04-01) -
Roles of mitochondrial ROS and NLRP3 inflammasome in multiple ozone-induced lung inflammation and emphysema
by: Feng Li, et al.
Published: (2018-11-01)